Viewing StudyNCT00413777



Ignite Creation Date: 2024-05-05 @ 5:13 PM
Last Modification Date: 2024-10-26 @ 9:29 AM
Study NCT ID: NCT00413777
Status: COMPLETED
Last Update Posted: 2017-07-02
First Post: 2006-12-18

Brief Title: Tolvaptan Open-label Pilot Efficacy Tolerability and Safety Study in Autosomal Dominant Polycystic Kidney Disease ADPKD
Sponsor: Otsuka Pharmaceutical Development Commercialization Inc
Organization: Otsuka Pharmaceutical Development Commercialization Inc

Key Dates - Follows AllAPIJSON File Order

Start Date: 2005-12
Start Date Type: None
Primary Completion Date: 2010-06
Primary Completion Date Type: ACTUAL
Completion Date: 2010-06
Completion Date Type: ACTUAL
First Submit Date: 2006-12-18
First Submit QC Date: December 18 2006
Study First Post Date: 2006-12-20
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2017-07-02
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: 2012-05-22
Disp First Submit QC Date: May 30 2012
Disp First Post Date: 2012-06-05
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2017-05-30
Last Update Post Date: 2017-07-02
Last Update Post Date Type: ACTUAL